[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  First Squawk [@FirstSquawk](/creator/twitter/FirstSquawk) on x 384.9K followers Created: 2025-07-17 11:02:06 UTC Bristol Myers Squibb and Pfizer launched a direct-to-patient option for ELIQUIS® (apixaban) and expanded the ELIQUIS XXX support program, giving cash-paying patients over XX% off the current price. XXXXX engagements  **Related Topics** [$bmy](/topic/$bmy) [stocks healthcare](/topic/stocks-healthcare) [$pfe](/topic/$pfe) [Post Link](https://x.com/FirstSquawk/status/1945801178425741491)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
First Squawk @FirstSquawk on x 384.9K followers
Created: 2025-07-17 11:02:06 UTC
Bristol Myers Squibb and Pfizer launched a direct-to-patient option for ELIQUIS® (apixaban) and expanded the ELIQUIS XXX support program, giving cash-paying patients over XX% off the current price.
XXXXX engagements
Related Topics $bmy stocks healthcare $pfe
/post/tweet::1945801178425741491